![Michael Schaeffer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/07/2026
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/04/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Crelux GmbH
 Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Director Ejecutivo | 01/03/2016 |
SiREEN AG
 SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Director Ejecutivo | 01/01/2004 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
SiREEN AG
SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Commercial Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
